BAY-1436032 | m-entrepreneurship.com

Product Name :
BAY-1436032

Search keywords :
BAY-1436032

drugId :
null

Target Vo:
Isocitrate dehydrogenase [NADP] cytoplasmic

Target Vo Short Name :
IDH1

Moa_Name:
Isocitrate dehydrogenase [NADP] cytoplasmic inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bayer AG

Active Company_Name :
Bayer AG

Active Indication_Name:
Solid tumours

In Active Indication_Name:
Leukemia, Myeloid, Acute

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ERK2 Rabbit mAb manufacturer
Bedinvetmab Biological Activity
Fas/CD95 Antibody: Fas/CD95 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to Fas(CD95). It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts